ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC007461.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC131097.4 | Protein LOC285095 | | | | | | Tissue enhanced |
ALDH1L2 | Aldehyde dehydrogenase 1 family, member L2 | Enzymes
| | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
ARSE | Arylsulfatase E (chondrodysplasia punctata 1) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BCAT1 | Branched chain amino-acid transaminase 1, cytosolic | Enzymes
| | | | | Tissue enhanced |
BRSK2 | BR serine/threonine kinase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
C2CD4B | C2 calcium-dependent domain containing 4B | | | | | | Tissue enhanced |
C8orf12 | Chromosome 8 open reading frame 12 | | | | | | Tissue enhanced |
C8orf47 | Chromosome 8 open reading frame 47 | | | | | | Tissue enhanced |
CABP7 | Calcium binding protein 7 | Predicted membrane proteins
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CHAC1 | ChaC, cation transport regulator homolog 1 (E. coli) | | | | | | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN9 | Claudin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLPSL2 | Colipase-like 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
CNPY1 | Canopy FGF signaling regulator 1 | | | | | | Tissue enhanced |
CTD-2600O9.1 | Uncharacterized protein LOC388282 | | | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
EGF | Epidermal growth factor | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EPHA8 | EPH receptor A8 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPO | Erythropoietin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
FFAR1 | Free fatty acid receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FUT1 | Fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) | Blood group antigen proteins Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
GJC3 | Gap junction protein, gamma 3, 30.2kDa | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJD2 | Gap junction protein, delta 2, 36kDa | Predicted membrane proteins
| | | | | Tissue enhanced |
GLP1R | Glucagon-like peptide 1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GPR119 | G protein-coupled receptor 119 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR150 | G protein-coupled receptor 150 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HOMER2 | Homer homolog 2 (Drosophila) | | | | | | Tissue enhanced |
IL22RA1 | Interleukin 22 receptor, alpha 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
LHB | Luteinizing hormone beta polypeptide | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
MATN4 | Matrilin 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYCL | V-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
NKX2-2 | NK2 homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
NKX6-1 | NK6 homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
NPHS1 | Nephrosis 1, congenital, Finnish type (nephrin) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
NRG4 | Neuregulin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
NUPR1 | Nuclear protein, transcriptional regulator, 1 | | | | | | Tissue enhanced |
ONECUT1 | One cut homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
PAK3 | P21 protein (Cdc42/Rac)-activated kinase 3 | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Tissue enhanced |
POMC | Proopiomelanocortin | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
POU6F2 | POU class 6 homeobox 2 | Disease related genes Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
REG1B | Regenerating islet-derived 1 beta | Predicted secreted proteins
| | | | | Tissue enhanced |
RP11-422N16.3 | Uncharacterized protein | | | | | | Tissue enhanced |
RP11-481A20.11 | Protein LOC101060662 | | | | | | Tissue enhanced |
SCGB2B2 | Secretoglobin, family 2B, member 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins
| | | | | Tissue enhanced |